"Have you done your best?" At the end of last year, Zhang Jinni, a negotiator of the National Medical Insurance Administration, "soul bargaining" at the drug negotiation site of the medical insurance catalog, and left a deep impression on people for eight consecutive rounds. Fina

2025/04/2503:02:36 regimen 1101

"Have you done your best?"

At the end of last year, the medical insurance catalog drug negotiation site

National Medical Insurance Administration negotiator Zhang Jinni "soul bargaining", cut eight rounds of

left a deep impression on people

Finally, treating rare diseases html

Finally, treating 5

Spinal muscular atrophy (SMA) drug

has been reduced from 700,000 yuan to 33,000 yuan

and has been included in the medical insurance directory

In response to this, Zhang Jinni said that she was "very happy" "I was trying to restrain myself at that time, Actually, the inner happiness

compares the table There are more to see"

Recently, Zhang Jinni shared the mental journey behind

"soul bargaining" for the first time↓

"sky-high drug"

became one of the targets of her negotiation of "price killing"

spinary muscular atrophy (SMA in English)

is a genetic defect caused by

autosomal recessive disease

patients mainly manifest as systemic muscle atrophy and weakness

body gradually loses various motor functions

In 2016, the world's first precise targeted drug for treating SMA—

Nosinaren sodium injection was released

In 2019, the injection was approved for sale in China

However, the price of at 700,000 yuan per injection

made the patients' just-ignited fire of hope

was soon extinguished

It is reported that the number of SMA patients in my country has about 30,000 to 50,000 to 50,000 people.

Let Nosinena sodium enter medical insurance

is their common call

November 2021, Fujian Provincial Medical Insurance Bureau

Medical Equipment Procurement Supervision Department Zhang Jinni

accepted a special task

For the national medical insurance negotiator

to negotiate medical insurance drug access with pharmaceutical manufacturers

and the "sky-high drug" nusina sodium

is in the drug directory participating in the negotiation

"These drugs for many patients

are life-saving things

. I really feel the responsibility of participating in the negotiation

1 I am studying clinical medicine origin

I know many diseases

What kind of life will

What kind of expectations do they have

including what impact will it have on his family "

she s the word "work" throughout

"Every small group should not be abandoned"

in the medical insurance directory drug negotiation site

"work" is Zhang Jinni consistent keyword

"You must be bigger . Work hard

. I really don’t want to have many routines. "

" In the thousand digits, you still need

. It’s not very small. . Work hard ”…

. In this regard, Zhang Jinni said in an interview that both parties have their own positions and angles

, so she also has “preparations for not being able to reach a conclusion”

ml9

"It is inevitable that it will not be possible to talk to

But from the goal,

Both parties hope to negotiate this medicine as

So we can only try to improve the negotiation success rate

"h During the negotiations of tml1, Zhang Jinni's sentence "Every small group should not be abandoned"

moved countless people

She said that she had never thought about this sentence in advance

"At that time, there was a certain sense of substitution

Rare disease patients are small groups

Maybe the right to speak

I I feel that if I encounter this kind of thing, what I hope for, what I was thinking at that time is "

Negotiated drug prices average drop of more than 50%

cumulative reduces the burden on patients by 300 billion

Currently, after medical insurance reimbursement of

patients are injected with Nuoxi The cost of Nashen sodium

will be reduced from 700,000 yuan of

to about 10,000 yuan

Starting from January 1, 2022

patients with spinal muscular atrophy

successively used the former "sky-high-priced medicine"

from 2 Since 018, the National Health Insurance Administration has included 507 drugs with high clinical value in

patients with significant benefits in payment scope

Negotiated average price drop in drug prices

between 50% and 60%

cumulatively reduced the burden on patients by 300 billion yuan

For this, Zhang Jinni was very pleased with

"Every serious patient has a very difficult family

Maybe you do one more thing

There will be a patient of a disease or family

You can get a better life "

regimen Category Latest News